NCT04601233View on ClinicalTrials.gov

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple SclerosisErectile DysfunctionTestosterone Deficiency
Interventions
DRUG

XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector

Self injection testosterone treatment

Trial Locations (1)

70112

LSU Health Multispecilaity Clinics, New Orleans

Sponsors

Collaborators (1)

Antares Pharma Inc.
All Listed Sponsors
collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

Antares Pharma Inc.

INDUSTRY

lead

Tulane University

OTHER